Biotechnology and bioengineering – Page 19
-
FeatureOn stranger nucleotides
Chemists have been making artificial DNA base pairs for 20 years. Josh Howgego investigates
-
NewsGM maize poised for approval in Europe
European commission is also examining the feasibility of allowing nationwide bans on engineered crops
-
NewsControversial GM maize cancer link paper retracted
Journal retracts paper for ‘inconclusive’ results while author vows to fight the decision
-
Business
Monsanto abandons GM crops in Europe
Company will focus on conventional plant breeding in EU and biotech elsewhere
-
NewsUS supreme court rules genes can't be patented
Breast cancer test company at centre of case can still rely on patents on non-naturally occurring DNA
-
NewsUS supreme court rules in favour of Monsanto
An Indiana farmer who was trying to replicate Monsanto-patented seeds infringed on the company’s intellectual property rights, the Supreme Court has determined
-
FeatureLean green microbe machines
For its proponents, algae hold the promise of a clean source of fuel, food or drugs. Anthony King wades in
-
NewsSanofi launches malaria drug production
French pharma firm set to supply a third of the world’s artemisinin next year with photochemical process
-
News
Golden rice trial breached ethical guidelines
Three Chinese researchers sacked after failing to tell participants parents that rice was genetically modified
-
ResearchLego-like DNA bricks are child’s play
Scientists make 32 nucleotide bricks that can snap together to build huge numbers of three-dimensional shapes
-
-
Business
Carbon dioxide to chemical partnership
Petronas to partner with gas fermentation specialist LanzaTech
-
NewsReview of GM cancer scare paper
Preliminary results will be reported next week after review of the controversial paper
-
FeatureSequencing in the fast lane
Advances in DNA sequencing technology are changing the way scientists look at genomes. Phillip Broadwith gets up to speed with the latest developments
-
CareersSuccouring success
Sarah Houlton reports on BioCity Nottingham, a start-up incubator helping fledgling companies find their feet
-
Opinion
Biotech's bravura performer
Bibiana Campos Seijo talks to scientist, philanthropist and serial entrepreneur Chris Evans
-
